This is a randomized, open label, comparative, Phase II study to determine whether fecal microbiota transplant using Penn Microbiome Therapy products helps standard therapy to treat severe Clostridium difficile infection (C diff).

Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)

A Phase II, Randomized Trial to Evaluate the Safety and Efficacy of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products for Severe or Severe-Complicated/Fulminant Clostridium Difficile Infection

Treatment Trials

Focus your search

Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)

Description

Conditions